Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CSHR | VTEX |
|---|---|---|
| Price | $4.82 | $3.84 |
| Change today | ▼ 2.82% | ▲ 1.05% |
| Market cap | $635.18M | $634.88M |
| Return, 3 months | +17.0% | -2.8% |
| Return, year to date | – | +2.1% |
| Return, 1 year | – | -15.6% |
| P/E (TTM) | -0.3 | 22.9 |
| P/B | 1.4 | 2.8 |
| P/E percentile vs own 5y | 67th | 60th |
| Dividend yield | 11.04% | – |
| Revenue growth (YoY, latest qtr) | +5.7% | +9.5% |
| Net profit growth (YoY) | +2.3% | +235.8% |
| Gross margin | 70.1% | 79.3% |
| Operating margin | -1,215.5% | 12.2% |
| Net margin | 9.3% | 12.0% |
| Return on equity | 3.0% | 12.8% |
| Analyst target vs. price | +107.5% | +17.2% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 40 | 64 |
| 30-day volatility | 66.9% | 21.7% |
| Max drawdown, 1 year | -58.4% | -37.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.